Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study

OBJECTIVE: To investigate the association between baseline disease activity and the occurrence of flares after adalimumab tapering or withdrawal in patients with rheumatoid arthritis (RA) in sustained remission. METHODS: The PREDICTRA phase IV, randomised, double-blind (DB) study (ImPact of Residual...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Burmester, Gerd R, Naredo, Esperanza, Sinigaglia, Luigi, Lagunes, Ivan, Koenigsbauer, Franziska, Conaghan, Philip G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392484/
https://www.ncbi.nlm.nih.gov/pubmed/32404343
http://dx.doi.org/10.1136/annrheumdis-2020-217246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392484/
https://www.ncbi.nlm.nih.gov/pubmed/32404343
http://dx.doi.org/10.1136/annrheumdis-2020-217246

Ejemplares similares